Blood-bank testing for infectious diseases: how safe is blood transfusion?
Remarkable progress has been made in transfusion safety from infection over the past three decades. Donor deferrals for at-risk behaviors, the introduction of more-sensitive viral-screening assays and the recent introduction of nucleic-acid amplification technology have nearly eliminated transmission of HIV and hepatitis C virus (HCV) by blood transfusion in North America. Nevertheless, risks of other infectious agents for which such robust screening tools have not been developed, such as bacteria and parasites, still remain. As a result of these successes, the non-infectious risks such as misidentification of patients and inadequate and inappropriate transfusion have become the primary sources of transfusion risk.
Strong
D Michael
DM
Puget Sound Blood Center and Program, 921 Terry Avenue, Seattle, WA 98104, USA. dmstrong@psbc.org
Katz
Louis
L
D001771:Blood Banks / Q000592:standards*; D001803:Blood Transfusion / Q000592:standards; D004797:Enzyme-Linked Immunosorbent Assay; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission; D006526:Hepatitis C / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007755:Laboratories, Hospital / Q000592:standards*; D065227:Transfusion Reaction